MyChesCo on MSN

Rajant clears federal security bar with high-stakes encryption certification

MALVERN, PA — Rajant Corporation said its In-Line Security Module has achieved Federal Information Processing Standard 140-3 ...
Cantech Letter

Quantum eMotion's QRNG Demonstrates Real-World Security Performance Across DeFi, Post-Quantum Simulation, and Federal Certification Path

Montreal, Quebec–(Newsfile Corp. – December 29, 2025) – Quantum eMotion (TSXV: QNC) (OTCQB: QNCCF) (FSE:34Q0) today highlighted a rare convergence of independent audit validation, quantum-attack ...
MarketWatch

Rajant's RiSM Achieves FIPS 140-3 Level 2 Certification, Strengthening Security for Defense and Regulated Environments

Rajant Corporation, the pioneer of Kinetic Mesh(R) wireless networking and distributed edge computing, today announced that the Rajant In-Line Security Module (RiSM) has officially achieved Federal ...
01Net

Rajant’s RiSM Achieves FIPS 140-3 Level 2 Certification, Strengthening Security for Defense and Regulated Environments

MALVERN, Pa.--(BUSINESS WIRE)--#CMVP--Rajant Corporation, the pioneer of Kinetic Mesh® wireless networking and distributed edge computing, today announced that the Rajant In-Line Security Module (RiSM ...
Yahoo Finance

Rajant’s RiSM Achieves FIPS 140-3 Level 2 Certification, Strengthening Security for Defense and Regulated Environments

FIPS 140-3 is the U.S. government’s benchmark for validating cryptographic modules used to protect sensitive information. While Level 1 certification focuses on validating cryptographic algorithms, ...
Yahoo Finance

Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced ...
manilatimes

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries

Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates ...